Along with expanding research into large-language models to rival OpenAI’s ChatGPC, the search-engine king is working on AI for improving maternal care, ultrasound access and tuberculosis screening.
“Many courses exist for teaching US scanning to non-radiologists, but fewer courses are available to radiologists who need to strengthen their core skills,” experts recently wrote in Academic Radiology.
Provention Bio's TZIELD is the first and only therapy to delay the onset of Stage 3 type 1 diabetes (T1D) in adults and pediatric patients aged 8 years and older with Stage 2 T1D.
After its initial release was limited to certain customers, the new-look catheter is now available in four different sizes throughout the United States.
FloPatch is a wireless, wearable, FDA-approved doppler ultrasound system that attaches directly to a patient’s neck to continuously monitor carotid blood flow during intravenous fluid therapy.